Published Date: 10 Mar 2023
China: A recent study by BMC Medicine has shown that the amount of insoluble fiber from various foods plays an important role...
Read Full NewsThe history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.
US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.
Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.
Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.
A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.
Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.
1.
finding fresh approaches to treating diffuse midline gliomas.
2.
Oral drug combination extends progression-free survival in advanced ER-positive breast cancer
3.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
4.
Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.
5.
A prostate cancer risk prediction algorithm could help target men at highest risk
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
Modern Updates in Hematology in the Digital Era
3.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
4.
The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery
5.
Hepatocellular Carcinoma: Emerging Trends and Innovations in Diagnosis and Management
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Breast Cancer Awareness and Early Detection
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XVI
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation